Photo of Tom Powles taken from bartscancer.london
May 26, 2024, 11:15
Tom Powles: 3 renal cancer biomarker orals at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:
“3 renal cancer biomarker orals at ASCO24 (Len/pem vs sun, axi/pem vs sun, atezo vs placebo). DNA, RNA, protein and blood (KIM1) data. .
Below is a summary of progress to date. Will this change or is it more exploratory data with problems more than solutions? Do 151RNA signatures have a future?”
Source: Tom Powles/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12